159 related articles for article (PubMed ID: 1545316)
21. [Combination chemotherapy with 5-FU and CDDP or CDDP analog for head and neck cancer].
Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M
Gan To Kagaku Ryoho; 1996 Nov; 23(13):1740-6. PubMed ID: 8937483
[TBL] [Abstract][Full Text] [Related]
22. Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-fluorouracil and uracil/tegafur.
Watanabe M; Nishida O; Kunii Y; Kodaira S; Takahashi T; Tominaga T; Hojyo K; Kato T; Niimoto M; Kunitomo K; Isomoto H; Ohashi Y; Yasutomi M
Int J Clin Oncol; 2004 Apr; 9(2):98-106. PubMed ID: 15108041
[TBL] [Abstract][Full Text] [Related]
23. Histologic differentiation and chemosensitivity of human head and neck squamous cell carcinomas.
Nakashima T; Maehara Y; Kohnoe S; Hayashi I; Katsuta Y
Head Neck; 1990; 12(5):406-10. PubMed ID: 2211101
[TBL] [Abstract][Full Text] [Related]
24. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
Hoff PM; Pazdur R; Benner SE; Canetta R
Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235
[TBL] [Abstract][Full Text] [Related]
25. General pharmacological properties of UFT, a new type of anti-cancer agent consisting of 1-(2-tetrahydrofuryl)-5-fluorouracil (FT) and uracil. I: Pharmacological analysis of the combined effect of FT and uracil.
Yamamoto J; Toide K; Haruno A; Yoshimura Y; Unemi N
Arzneimittelforschung; 1981; 31(8):1268-78. PubMed ID: 6794578
[TBL] [Abstract][Full Text] [Related]
26. Accuracy of the subrenal capsule xenograft assay in predicting the clinical growth and chemosensitivity of human squamous head and neck carcinomas.
Parnes SM; Bennett JA; Deconti RC; Sagerman P
J Surg Oncol; 1989 Sep; 42(1):21-7. PubMed ID: 2770306
[TBL] [Abstract][Full Text] [Related]
27. Neoadjuvant therapy with cisplatin/fluorouracil vs cisplatin/UFT in locally advanced squamous cell head and neck cancer.
González-Larriba JL; Garcia Carbonero I; Sastre Valera J; Perez Segura P; Diaz-Rubio E
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):90-7. PubMed ID: 9348577
[TBL] [Abstract][Full Text] [Related]
28. Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC).
Rivera F; Vega-Villegas ME; López-Brea M; Isla D; Mayorga M; Galdós P; Rubio A; Del Valle A; García-Reija F; García-Montesinos B; Rodríguez-Iglesias J; Mayordomo J; Rama J; Saiz-Bustillo R; Sanz-Ortiz J
Cancer Chemother Pharmacol; 2008 Jul; 62(2):253-61. PubMed ID: 17901953
[TBL] [Abstract][Full Text] [Related]
29. [Light and electron microscopic examination compared to evaluation by tumor size in subrenal capsule assay for chemosensitivity testing in esophageal cancer].
Akao S; Oya M; Ishikawa H; Kiumi F
Gan To Kagaku Ryoho; 1995 Oct; 22(12):1813-9. PubMed ID: 7574815
[TBL] [Abstract][Full Text] [Related]
30. [Antineoplastic effect of UFT therapy (uracil-FT-207 combination therapy) on experimental pancreatic cancer transplanted in the pancreas and subcutaneous region].
Ohyama K; Koike D; Odake Y; Takiyama Y; Saitoh T; Kagaya T; Takebe T; Ishii K
Gan To Kagaku Ryoho; 1982 Dec; 9(12):2168-74. PubMed ID: 6307180
[TBL] [Abstract][Full Text] [Related]
31. [Responsiveness of gynecological malignancies to oral antitumor agents in subrenal capsule assay and individualization of oral adjuvant chemotherapy].
Sekiguchi I; Suzuki M; Aida I; Tamada T; Nishida M
Nihon Sanka Fujinka Gakkai Zasshi; 1990 May; 42(5):437-42. PubMed ID: 2115558
[TBL] [Abstract][Full Text] [Related]
32. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of prostatic carcinoma with UFT and leucovorin--basic study using SRCA].
Uchida K; Hayashi T; Shiga T; Hattori K; Nishijima Y; Kasaya S; Shimazui T; Akaza H; Koiso K; Nemoto R
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2633-7. PubMed ID: 7979424
[TBL] [Abstract][Full Text] [Related]
34. A phase II study of combined oral uracil and ftorafur with leucovorin for patients with squamous cell carcinoma of the head and neck.
Colevas AD; Amrein PC; Gomolin H; Barton JJ; Read RR; Adak S; Benner S; Costello R; Posner MR
Cancer; 2001 Jul; 92(2):326-31. PubMed ID: 11466686
[TBL] [Abstract][Full Text] [Related]
35. [Comparative pharmacokinetic study between UFT and FT-207 suppo and phase II studies in gynecological malignancies].
Hatae M; Terahara M; Hokanishi H
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2386-92. PubMed ID: 6437345
[TBL] [Abstract][Full Text] [Related]
36. Antitumor activity and low intestinal toxicity of S-1, a new formulation of oral tegafur, in experimental tumor models in rats.
Takechi T; Nakano K; Uchida J; Mita A; Toko K; Takeda S; Unemi N; Shirasaka T
Cancer Chemother Pharmacol; 1997; 39(3):205-11. PubMed ID: 8996521
[TBL] [Abstract][Full Text] [Related]
37. Subrenal capsule assay using nude mice as a predictor of the response of the gastric cancer to chemotherapy.
Yamauchi M; Satta T; Ito A; Kondo K; Akiyama S; Ito K; Watanabe T; Takagi H
J Surg Oncol; 1991 Jun; 47(2):98-101. PubMed ID: 1905767
[TBL] [Abstract][Full Text] [Related]
38. Studies on the metabolism of 1-(2-tetrahydrofuryl)-5-fluorouracil and uracil co-administered orally to tumor-bearing rats.
Kawaguchi Y; Nagayama S; Masuda H; Yasuda A
Gan; 1980 Dec; 71(6):889-99. PubMed ID: 6791982
[TBL] [Abstract][Full Text] [Related]
39. [Combined chemotherapy with low-dose cisplatin, tegafur and uracil for head and neck squamous cell carcinomas].
Nishino H; Abe K; Ishikawa K; Kanazawa T; Tanaka H; Miyata M; Kitamura K; Morita M
Gan To Kagaku Ryoho; 1999 Oct; 26(11):1617-21. PubMed ID: 10553420
[TBL] [Abstract][Full Text] [Related]
40. [Evaluation of subrenal capsule assay (SRC) for clinical cancers].
Akao S; Iwami N; Oya M; Terada H; Sasaki K; Ishikawa H; Kiumi F
Gan To Kagaku Ryoho; 1996 Apr; 23(5):607-13. PubMed ID: 8678520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
